250 related articles for article (PubMed ID: 29430505)
1. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.
Li R; Metcalfe M; Kukreja J; Navai N
Bladder Cancer; 2018 Jan; 4(1):31-40. PubMed ID: 29430505
[TBL] [Abstract][Full Text] [Related]
2. The Role of Lymph Node Dissection in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy Following Neoadjuvant Chemotherapy.
Zennami K; Takahara K; Nukaya T; Takenaka M; Ichino M; Sasaki H; Kusaka M; Sumitomo M; Shiroki R
Clin Genitourin Cancer; 2024 Apr; 22(2):1-9. PubMed ID: 37423863
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
Guo Y; Jie X; Zhang A; Zhang W; Wang R; Zhang J; Mao S; Wu Y; Wang L; Zhang Z; Yan Y; Wang P; Yao X
Front Oncol; 2019; 9():1315. PubMed ID: 31867271
[No Abstract] [Full Text] [Related]
4. The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
Afferi L; Zamboni S; Karnes RJ; Roghmann F; Sargos P; Montorsi F; Briganti A; Gallina A; Mattei A; Schulz GB; Hendricksen K; Voskuilen CS; Rink M; Poyet C; De Cobelli O; di Trapani E; Simeone C; Soligo M; Simone G; Tuderti G; Alvarez-Maestro M; Martínez-Piñeiro L; Aziz A; Shariat SF; Abufaraj M; Xylinas E; Moschini M;
World J Urol; 2021 Feb; 39(2):443-451. PubMed ID: 32356226
[TBL] [Abstract][Full Text] [Related]
5. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
Gschwend JE; Heck MM; Lehmann J; Rübben H; Albers P; Wolff JM; Frohneberg D; de Geeter P; Heidenreich A; Kälble T; Stöckle M; Schnöller T; Stenzl A; Müller M; Truss M; Roth S; Liehr UB; Leißner J; Bregenzer T; Retz M
Eur Urol; 2019 Apr; 75(4):604-611. PubMed ID: 30337060
[TBL] [Abstract][Full Text] [Related]
6. Lymph node dissection in bladder cancer. Impact on staging and prognosis.
Jensen JB
Dan Med J; 2012 Dec; 59(12):B4559. PubMed ID: 23290294
[TBL] [Abstract][Full Text] [Related]
7. The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.
Abufaraj M; Dalbagni G; Daneshmand S; Horenblas S; Kamat AM; Kanzaki R; Zlotta AR; Shariat SF
Eur Urol; 2018 Apr; 73(4):543-557. PubMed ID: 29122377
[TBL] [Abstract][Full Text] [Related]
8. Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy.
von Landenberg N; Speed JM; Cole AP; Seisen T; Lipsitz SR; Gild P; Menon M; Kibel AS; Roghmann F; Noldus J; Sun M; Trinh QD
Urol Oncol; 2018 Feb; 36(2):78.e13-78.e19. PubMed ID: 29169845
[TBL] [Abstract][Full Text] [Related]
9. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.
Khanna A; Miest T; Sharma V; Campbell R; Hensley P; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Murthy PB; Haber GP; Navai N; Kamat AM; Dinney C; Lee B; Boorjian SA
J Urol; 2022 Mar; 207(3):551-558. PubMed ID: 34694143
[TBL] [Abstract][Full Text] [Related]
10. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
[TBL] [Abstract][Full Text] [Related]
11. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins HM; Skinner EC; Dorin RP; Ahmadi H; Djaladat H; Miranda G; Cai J; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):24.e13-9. PubMed ID: 23395238
[TBL] [Abstract][Full Text] [Related]
12. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.
Eapen R; Liew MS; Tafreshi A; Papa N; Lawrentschuk N; Azad A; Davis ID; Bolton D; Sengupta S
ANZ J Surg; 2015; 85(7-8):535-9. PubMed ID: 25040795
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231
[TBL] [Abstract][Full Text] [Related]
15. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
Heck MM; Koll FJ; Retz M; Autenrieth M; Magg K; Lunger L; Gschwend JE; Nawroth R
Urol Oncol; 2020 Jul; 38(7):639.e11-639.e19. PubMed ID: 32146127
[TBL] [Abstract][Full Text] [Related]
16. Partial and radical cystectomy provides equivalent oncologic outcomes in bladder cancer when combined with adequate lymph node dissection: A population-based study.
Long G; Hu Z; Liu Z; Ye Z; Wang S; Wang D; Yang C
Urol Oncol; 2023 Jul; 41(7):327.e1-327.e8. PubMed ID: 36966065
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H
Sci Rep; 2019 Jun; 9(1):8305. PubMed ID: 31165753
[TBL] [Abstract][Full Text] [Related]
18. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
19. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
